To summarize, our study is the first to prospectively assess HSPC phenotype in patients with CAD and is unique in providing a comprehensive phenotype by the integration of powerful tools such as RNAseq on flow-sorted HSPC populations, functional parameters, Seahorse respiratory, and PET imaging of vascular wall and hematopoietic activity. The gene discussed is PSMA7; the disease is coronary artery disorder.